SURG.VSURG.VTSXV
Loading
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | -0 | -0 | -0 |
| Operating Income | -5 | -4 | -3 |
| Net Income | -6 | -5 | -2 |
| EBITDA | -4 | -2 | -2 |
| EPS Diluted | -0.06 | -0.03 | -0.01 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Cash & Equivalents | 3 | 8 | 3 |
| Total Current Assets | 4 | 8 | 3 |
| Total Assets | 34 | 47 | 50 |
| Total Current Liabilities | 0 | 2 | 1 |
| Total Liabilities | 2 | 6 | 6 |
| Total Equity | 32 | 42 | 45 |
| Total Debt | 0 | 0 | 0 |
| Net Debt | -3 | -8 | -3 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Operating Cash Flow | -1 | -2 | -1 |
| Capital Expenditure | -0 | -0 | -0 |
| Free Cash Flow | -2 | -2 | -1 |
| Stock-Based Comp | 4 | 2 | 2 |
| Net Change in Cash | 3 | 5 | -5 |